Shares of Incyte Corp. /zigman2/quotes/204510994/composite INCY +2.19% rallied 1.54% to $87.53 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.02% rising 0.47% to 4,239.18 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.36% rising 0.06% to 34,466.24. This was the stock's second consecutive day of gains. Incyte Corp. closed $22.84 below its 52-week high ($110.37), which the company reached on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Pfizer Inc. /zigman2/quotes/202877789/composite PFE +3.21% rose 2.19% to $40.68, Novartis AG ADR /zigman2/quotes/203243705/composite NVS +0.62% rose 1.38% to $93.50, and Eli Lilly & Co. /zigman2/quotes/200106384/composite LLY +1.20% rose 3.34% to $233.54. Trading volume (893,497) remained 195,459 below its 50-day average volume of 1.1 M.